Amel Tounsi
InvestorInvestment Manager at Meusinvest (Noshaq)
Brussels
Writes $100K – $5M checks · typically $1.5M
Find your path to Amel
305 people in our graph can introduce you to Amel.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Rudy Dekeyser to introduce you to Amel
You →Rudy · together at Celyad (2013–2014) →Amel
Ask Jamie Chen to introduce you to Amel
You →Jamie · 2 people · together at Celyad →Amel
Ask Sam Okafor to introduce you to Amel
You →Sam · 5 people · together at University of Strasbourg →Amel
Sign up to find every way you can get introduced to Amel
- Your email: the people you already email who know Amel
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Amel
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Amel Tounsi is Chief Executive Officer at Bridge to Health and Investment Manager at Noshaq. With over 15 years of leadership experience in biotech, advanced therapies, and health innovation ecosystems, he holds a scientific background in immunology and cell therapy. In his current roles, Tounsi has led regional and cross-border collaborations and worked to develop integrated health innovation systems across multiple sectors.
Experience
- Bridge to HealthChief Executive Officercurrent2022 — presentLiège
- NoshaqInvestment Managercurrent2021 — present
- Texere BiotechChief Operations Officer2018 — 2021
- Texere BiotechChief Operating Officer2017 — 2020
- MaSTherCellProject & Development Manager2014 — 2017
- MaSTherCellProject Manager2014 — 2017
- Cardio3 BiosciencesProject Lead2013 — 2014
- Cardio3 BiosciencesResearch And Development Scientist2011 — 2013
- Cardio3 BiosciencesR&D Scientist2011 — 2013
- CelyadProject Leader2013 — 2014
- DKFZPost Doctoral Fellow2009 — 2010Heidelberg Area, Germany
- Ludwig Institute for Cancer ResearchPhD Student2004 — 2008Brussels Area, Belgium
Skills & more
Languages Arabic · English
From Amel's professional profile.
Investments
Investor
Amyl Therapeutics
Per curated public sources.
Colleagues at Meusinvest (Noshaq)
Network7
Investors connected to Amel in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Amel Tounsi?
- Amel Tounsi is Chief Executive Officer at Bridge to Health and Investment Manager at Noshaq. With over 15 years of leadership experience in biotech, advanced therapies, and health innovation ecosystems, he holds a scientific background in immunology and cell therapy. In his current roles, Tounsi has led regional and cross-border collaborations and worked to develop integrated health innovation systems across multiple sectors.
- Where does Amel Tounsi work?
- Amel Tounsi is Investment Manager at Meusinvest (Noshaq).
- What check size does Amel Tounsi write?
- Amel Tounsi typically writes checks of $100K – $5M.
- What companies has Amel Tounsi invested in?
- Investments tracked here include Amyl Therapeutics.
- Where did Amel Tounsi go to school?
- Amel Tounsi studied at Solvay Brussels School of Economics and Management (Accelerated Management Programme, LEadership-Project Managment-Marketing-Accounting-Finance-Strategic Management); Université catholique de Louvain (PhD, Biomedical studies); European Directorate for the Quality of Medicines & HealthCare (Symposium on Raw Materials for the Production of Cell-based and Gene Therapy Products').
Same school
Also attended Université catholique de Louvain117
+ 111 more
Also attended University of Strasbourg30
+ 24 more
Shared employers
Also worked at Texere Biotech1
Also worked at Celyad5
Also worked at DKFZ16
+ 10 more
Also worked at Ludwig Institute for Cancer Research9
+ 3 more














































